This compound is a derivative of abiraterone acetate, specifically recognized as an impurity associated with the manufacture of the pharmaceutical active ingredient. It features a steroidal backbone with a pyridine ring and an ester functional group, and its stereochemistry is well-defined.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2484719-10-8
(3beta)-16-[(3beta)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
Abiraterone related compound
17-(3-Pyridinyl)-3-propanoate-androsta-5,16-dien-3-ol
active pharmaceutical ingredient
Abiraterone Impurity 54
Reference standard for impurity testing
3-Deoxy-3-chloroabiraterone (Mixture of Diastereomers)
Abiraterone acetate impurity
Beta-Epoxyabiraterone acetate
Active pharmaceutical ingredient for cancer
Alpha-Epoxyabiraterone acetate
pharmaceutical raw material
Dantrolene sodium hemiheptahydrate
muscle relaxant active pharmaceutical ingredient
Aceglutamide
nootropic and antiulcer agent
[(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
UVIQSJCZCSLXRZ-BRSOJCHPSA-N
CC(=O)O[C@@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
—